PARP regulates TGF-β receptor type II expression in estrogen receptor-positive breast cancer cell lines

被引:0
|
作者
Sterling, Julie A. [1 ]
Wu, Liang [1 ]
Banerji, Sunandita S. [1 ]
机构
[1] Med Univ Ohio, Dept Biochem & Canc Biol, Toledo, OH 43614 USA
关键词
TGF-beta receptor type II; estrogen receptor-positive; breast cancer; PARP; CCAAT box;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Expression of the tumor suppressor gene, transforming growth factor beta receptor type II (T beta RII) is often reduced in estrogen receptor-positive breast cancer cells leading to uninhibited tumor cell growth. A clear understanding of its regulation is necessary to identify potential mechanisms to re-express this tumor suppressor gene. Materials and Methods: The regulation of T beta RII expression was studied by utilizing 5' promoter deletion constructs, followed by EMSA analyses. The resulting binding protein was affinity purified and identified by mass spectrophotometry. Results: An inverted CCAAT box centered at -79 was found to be essential for T beta RII promoter activity. Purification of the protein binding to this region and subsequent mass spectrophotometric analysis identified the binding protein as poly(ADP-ribose)polyinerase I (PARP). ChIP assays verified that PARP interacted with the TPRII promoter in vivo. Conclusion: The present study demonstrated that PARP is important for T beta RII expression in estrogen receptor-positive breast cancer cell lines.
引用
收藏
页码:1893 / 1901
页数:9
相关论文
共 50 条
  • [31] Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
    Derek F. Amanatullah
    John S. Tamaresis
    Pauline Chu
    Michael H. Bachmann
    Nhat M. Hoang
    Deborah Collyar
    Aaron T. Mayer
    Robert B. West
    William J. Maloney
    Christopher H. Contag
    Bonnie L. King
    Breast Cancer Research, 19
  • [32] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [33] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [34] Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
    Datta, Jharna
    Willingham, Natalie
    Manouchehri, Jasmine M.
    Schnell, Patrick
    Sheth, Mirisha
    David, Joel J.
    Kassem, Mahmoud
    Wilson, Tyler A.
    Radomska, Hanna S.
    Coss, Christopher C.
    Bennett, Chad E.
    Ganju, Ramesh K.
    Sardesai, Sagar D.
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Stover, Daniel G.
    Cherian, Mathew A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] INFLUENCE OF DIFFERENT COMBINATIONS OF TAMOXIFEN AND TOREMIFENE ON ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER CELL-LINES
    CORADINI, D
    BIFFI, A
    CAPPELLETTI, V
    DIFRONZO, G
    CANCER DETECTION AND PREVENTION, 1995, 19 (04): : 348 - 354
  • [36] Estrogen-mediated mechanisms in estrogen receptor-positive breast cancer at the single cell level
    Mori, Hitomi
    Saeki, Kohei
    Chang, Gregory
    Wang, Jinhui
    Wu, Xiwei
    Hsu, Pei-Yin
    Kanaya, Noriko
    Somlo, George
    Nakamura, Masafumi
    Bild, Andrea
    Chen, Shiuan
    CANCER RESEARCH, 2022, 82 (04)
  • [37] Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models
    Lambouras, Maria
    Roelofs, Charlotte
    Pereira, Melrine
    Gruber, Emily
    Vieusseux, Jessica L.
    Lanteri, Patrick
    Johnstone, Cameron N.
    Muntz, Fenella
    O'Toole, Sandra
    Ooms, Lisa M.
    Mitchell, Christina A.
    Anderson, Robin L.
    Britt, Kara L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [38] MicroRNAs in estrogen receptor-positive and -negative breast cancer cells
    Miyamoto, Kazuaki
    Miyamoto, Haruko
    CANCER RESEARCH, 2009, 69
  • [39] A novel oncogenic enhancer of estrogen receptor-positive breast cancer
    Bao, Chunjie
    Duan, Jialun
    Xie, Ying
    Liu, Yixuan
    Li, Peishan
    Li, Jianwei
    Zhao, Huihui
    Guo, Haitao
    Men, Yanchen
    Ren, Yuxin
    Xu, Jiarui
    Wang, Guiling
    Lu, Wanliang
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 29 : 836 - 851
  • [40] Update on estrogen receptor-positive breast cancer risk reduction
    Vogel V.G.
    Current Breast Cancer Reports, 2011, 3 (3) : 156 - 164